Cargando…

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma

IMPORTANCE: Hodgkin lymphoma (HL) survivors have higher rates of colorectal cancer, which may be associated with subdiaphragmatic radiation therapy and/or alkylating chemotherapy. Although radiation dose-response associations with breast, lung, stomach, pancreatic, and esophageal cancer after HL hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geurts, Yvonne M., Shakir, Rebecca, Ntentas, Georgios, Roberti, Sander, Aznar, Marianne C., John, Katinka M., Ramroth, Johanna, Janus, Cécile P. M., Krol, Augustinus D. G., Roesink, Judith M., van der Maazen, Richard W. M., Zijlstra, Josée M., Darby, Sarah C., Aleman, Berthe M. P., van Leeuwen, Flora E., Cutter, David J., Schaapveld, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896374/ https://www.ncbi.nlm.nih.gov/pubmed/36729438 http://dx.doi.org/10.1001/jamaoncol.2022.7153

Ejemplares similares

P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
por: Geurts, Yvonne M.G., et al.
Publicado: (2022)

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
por: van Eggermond, Anna M, et al.
Publicado: (2017)

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy
por: Ykema, Berbel L.M., et al.
Publicado: (2022)

Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2015)

Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer
por: Rigter, Lisanne S., et al.
Publicado: (2018)

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors
por: de Vries, Simone, et al.
Publicado: (2018)

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
por: de Vries, Simone, et al.
Publicado: (2020)

P077: Predicting radiotherapy dose to the heart and the risk of radiation-related cardiac toxicity for Hodgkin lymphoma patients, using pre-chemotherapy PET-CT scans
por: Shakir, Rebecca, et al.
Publicado: (2022)

P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
por: Nijdam, Annelies, et al.
Publicado: (2022)

Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection
por: Ntentas, Georgios, et al.
Publicado: (2022)

P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
por: Lammers, Eline M.J., et al.
Publicado: (2022)

Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data
por: Juul, Sidsel Jacobsen, et al.
Publicado: (2022)

Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry
por: Jones, David A., et al.
Publicado: (2022)

P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England
por: Jones, David, et al.
Publicado: (2022)

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics
por: de Vries, Simone, et al.
Publicado: (2018)

Cardiovascular disease incidence rates: a study using routinely collected health data
por: Ramroth, Johanna, et al.
Publicado: (2023)

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors
por: Ykema, Berbel L. M., et al.
Publicado: (2021)

P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment
por: Mieras, Adinda, et al.
Publicado: (2022)

T022: Sharing decisions regarding radiotherapy for Hodgkin lymphoma: a qualitative study of the experiences of patients and clinicians in the UK
por: Shakir, Rebecca, et al.
Publicado: (2022)

Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors
por: Roberti, Sander, et al.
Publicado: (2022)

Protection of rat spermatogenic epithelium from damage induced by procarbazine chemotherapy.
por: Glode, L. M., et al.
Publicado: (1990)

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
por: Boekel, Naomi B., et al.
Publicado: (2014)

Clomiphene citrate reduces procarbazine-induced sterility in a rat model.
por: Weissenberg, R., et al.
Publicado: (1995)

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors
por: Rigter, Lisanne S., et al.
Publicado: (2018)

Procarbazine, CCNU, and Vincristine Chemotherapy in Gliomatosis Cerebri
por: Lee, Hyun Gon, et al.
Publicado: (2014)

Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009
por: Duane, Frances K., et al.
Publicado: (2022)

Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
por: Ykema, Berbel, et al.
Publicado: (2020)

A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
por: McElwain, T. J., et al.
Publicado: (1977)

T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
por: Neppelenbroek, Suzanne I.M., et al.
Publicado: (2022)

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
por: Ntentas, Georgios, et al.
Publicado: (2019)

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors
por: Armand, Jean-Pierre, et al.
Publicado: (2007)

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2021)

Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
por: Jacobse, Judy N., et al.
Publicado: (2019)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
por: Rigter, Lisanne S., et al.
Publicado: (2017)

Heart failure after treatment for breast cancer
por: Boekel, Naomi B., et al.
Publicado: (2019)

Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation
por: Kim, Se-Hyuk, et al.
Publicado: (2018)

Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer
por: Rigter, Lisanne S., et al.
Publicado: (2022)

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
por: Yung, W K A, et al.
Publicado: (2000)

Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA)
por: Krul, Inge M, et al.
Publicado: (2018)

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
por: Boekel, Naomi B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r8n2l6df2csq5tcneqndd3dhj2